Intuitive Surgical Inc (ISRG) - Multiplikator forward rega marang pendapatan
Intuitive Surgical generates revenue through the sale of da Vinci systems and ancillary services. The forward price-to-sales ratio on the GURU.Markets daily chart shows that the value is holding at 9.00. Gary Guthart's strategy ensures niche dominance through R&D, while the increasing number of procedures creates powerful leverage to boost profits from consumables.
Intuitive Corp - rincian analitis lan metrik utama (ISRG)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Intuitive Surgical|ISRG - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Intuitive Surgical|ISRG - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Intuitive Corp|ISRG - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Intuitive Surgical|Likuiditas cepet intuitive.com
- data bathi bisnis lan rasio investasi:
ISRG - Bathi perusahaan|Bathi mangsa ngarep Intuitive Surgical|ISRG - Rasio rega pasar marang bathi resik|Prakiraan rega marang bathi Intuitive Surgical Inc|ISRG - Pangali PEG|Pangali EV/EBITDA Intuitive Corp|ISRG - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Intuitive Surgical|ISRG - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan intuitive.com|ISRG - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Intuitive Surgical
- data dodolan lan asil:
Analisis umum perusahaan:ISRG (Intuitive)
To assess the credit quality of Intuitive Surgical (ISRG), the analyst compares market value with expected revenue. Stable demand for robotic surgeries minimizes revenue volatility, making the future P/S ratio a reliable indicator of overbought conditions. An increase in this metric signals inflated market expectations, whereas its decline amid a stable business opens a window for a fundamentally justified entry.
Analisis perusahaan pesaing
Rasio rega marang prakiraan pendapatan Danaher DHR|Rega forward marang dodolan BDX|STE: Multiplikator forward rega marang pendapatan|WST - Multiplikator Forward P/S|Baxter International (BAX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan masimo.com|STVN (Stevanato Group) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Teleflex Inc. TFX|Rasio rega marang prakiraan pendapatan Merit Medical Systems Inc (MMSI)|Nobel Biocare - Kapitalisasi marang prakiraan pendapatan|ICU Medical, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake XRAY (dentsplysirona.com)|LMAT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake AtriCure Inc ATRC|STAA: Multiplikator Forward P/S|NAGE - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan ZimVie Inc.|Kapitalisasi marang prakiraan pendapatan ANGO (angiodynamics.com)|Multiplikator forward rega marang pendapatan CERS (Cerus)|Rasio rega marang pendapatan sing dikarepake TKNO|Monogram Technologies Inc - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Sharps Technology Inc STSS|InfuSystem Inc - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake utahmed.com UTMD|KRMD (korumedical.com) - Multiplikator forward rega marang pendapatan|NYXH: Rasio rega marang pendapatan sing dikarepake|MBOT (Microbot Medical Inc) - Multiplikator Forward P/S|Pro-Dex Inc. (PDEX) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan ZTEK (Zentek Ltd.)|Rasio rega marang prakiraan pendapatan ELUT (elutia.com)|Multiplikator Forward P/S MLSS (Milestone Scientific Inc.)|NEXGEL Inc. (NXGL) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|RVP: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan HBIO (harvardbioscience.com)|Femasys Inc. (FEMY) - Rasio rega marang prakiraan pendapatan|MHUA - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan POAI|Multiplikator Forward P/S Callan JMB Corp|Rasio rega marang prakiraan pendapatan Atrion Corp (ATRI)|NURO (NeuroMetrix Corporation) - Rega forward marang dodolan
